Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/34465
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2023-10-19T11:53:36Z | - |
dc.date.available | 2023-10-19T11:53:36Z | - |
dc.date.issued | 2020-05 | - |
dc.identifier.citation | Sağ, S. ve Gül, Ö. Ö. (2020). "Mental status and physical activity in patients with homozygous familial hypercholesterolemia: A subgroup analysis of a nationwide survey (A-HIT1 registry)". Journal of Clinical Lipidology, 14(3), 361-370. | en_US |
dc.identifier.issn | 1933-2874 | - |
dc.identifier.issn | 1876-4789 | - |
dc.identifier.uri | https://doi.org/10.1016/j.jacl.2020.04.006 | - |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S1933287420300763 | - |
dc.identifier.uri | http://hdl.handle.net/11452/34465 | - |
dc.description | Bu çalışmada 23 yazar bulunmaktadır. Bu yazarlardan sadece Bursa Uludağ Üniversitesi mensuplarının girişleri yapılmıştır. | tr_TR |
dc.description.abstract | BACKGROUND: Homozygous familial hypercholesterolemia (HoFH) is a rare, life-threatening disease due to high serum low-density lipoprotein (LDL) cholesterol levels. LDL cholesterol-lowering interventions are fundamental for patients with HoFH. OBJECTIVE: It was aimed to investigate the association between the mental status of patients with HoFH and healthy lifestyle behaviors. METHODS: This subgroup analysis of the A-HIT1 population included the data of patients aged >= 18 years with a clinical diagnosis of HoFH undergoing therapeutic LDL apheresis. Besides the demographic and clinical characteristics of patients, healthy lifestyle behaviors were assessed, and psychiatric symptoms were screened by Symptom Check List (SCL-90-R). RESULTS: The highest percentage for pathology was observed in dimensions of obsessive-compulsive, somatization, interpersonal sensitivity, and depression in SCL-90-R. Patients with any cardiovascular condition have more psychiatric symptoms in different fields of SCL-90-R. The outcomes of the correlative analysis indicated that lower the age of the first coronary event better the psychiatric status, probably denoting a better adaptation to disease and its treatment. Among 68 patients, 36 patients were not exercising regularly. Patients with regular physical activity had significantly lower scores in most dimensions of SCL-90-R and there was no association between regular physical activity and other investigated variables. The strongest predictor of regular exercising was global severity index of SCL-90-R. CONCLUSION: In the HoFH population, there was a high prevalence of mental disturbances. Better psychiatric status was associated with regular exercising. Therefore, assessing the mental status of patients with HoFH and referring patients in need, to a psychiatrist, may improve the outcome of patients. | en_US |
dc.description.sponsorship | Abdi İbrahim | tr_TR |
dc.description.sponsorship | Aegerion pharmaceuticals | en_US |
dc.description.sponsorship | Glaxo Smith Kline | en_US |
dc.description.sponsorship | Abbott Laboratories | en_US |
dc.description.sponsorship | Pfizer | en_US |
dc.description.sponsorship | Astellas Pharma US | en_US |
dc.description.sponsorship | AstraZeneca | en_US |
dc.description.sponsorship | Johnson and Johnson | en_US |
dc.description.sponsorship | Merck | en_US |
dc.description.sponsorship | Novartis | en_US |
dc.description.sponsorship | Roche | en_US |
dc.description.sponsorship | Sanofi | en_US |
dc.description.sponsorship | Actelion Pharmaceuticals | en_US |
dc.description.sponsorship | Boehringer Ingelheim | en_US |
dc.description.sponsorship | Sanofi Genzyme | en_US |
dc.description.sponsorship | Novo Nordisk | en_US |
dc.description.sponsorship | Bayer Schering | en_US |
dc.description.sponsorship | Servier | en_US |
dc.description.sponsorship | Ipsen | en_US |
dc.description.sponsorship | Aegerion | en_US |
dc.description.sponsorship | Amgen | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Pharmacology & pharmacy | en_US |
dc.subject | Homozygous familial hypercholesterolemia | en_US |
dc.subject | Global severity index | en_US |
dc.subject | HoFH | en_US |
dc.subject | LDL | en_US |
dc.subject | LDL apheresis | en_US |
dc.subject | Mental state | en_US |
dc.subject | Physical activity | en_US |
dc.subject | Psychiatry | en_US |
dc.subject | Psychopathology | en_US |
dc.subject | Symptom check list | en_US |
dc.subject | LDL-apheresis | en_US |
dc.subject | Patients perceptions | en_US |
dc.subject | Risk-factors | en_US |
dc.subject | Self | en_US |
dc.subject | Life | en_US |
dc.subject | Intervention | en_US |
dc.subject | Depression | en_US |
dc.subject | Management | en_US |
dc.subject | Disorder | en_US |
dc.subject | People | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Anticholesteremic agents | en_US |
dc.subject.mesh | Cholesterol, LDL | en_US |
dc.subject.mesh | Exercise | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Homozygote | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Hyperlipoproteinemia type II | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Mental health | en_US |
dc.subject.mesh | Middle aged | en_US |
dc.subject.mesh | Phenotype | en_US |
dc.subject.mesh | Registries | en_US |
dc.subject.mesh | Surveys and questionnaires | en_US |
dc.title | Mental status and physical activity in patients with homozygous familial hypercholesterolemia: A subgroup analysis of a nationwide survey (A-HIT1 registry) | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000540548500013 | tr_TR |
dc.identifier.scopus | 2-s2.0-85085098192 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Kardiyoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Endokrinoloji Anabilim Dalı. | tr_TR |
dc.identifier.startpage | 361 | tr_TR |
dc.identifier.endpage | 370 | tr_TR |
dc.identifier.volume | 14 | tr_TR |
dc.identifier.issue | 3 | tr_TR |
dc.relation.journal | Journal of Clinical Lipidology | en_US |
dc.contributor.buuauthor | Sağ, Saim | - |
dc.contributor.buuauthor | Gül, Özen Öz | - |
dc.contributor.researcherid | AAW-9185-2020 | tr_TR |
dc.contributor.researcherid | AAI-1005-2021 | tr_TR |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.relation.collaboration | Sanayi | tr_TR |
dc.identifier.pubmed | 32423761 | tr_TR |
dc.subject.wos | Pharmacology & pharmacy | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.wos | SSCI | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q2 | en_US |
dc.contributor.scopusid | 12140008100 | tr_TR |
dc.contributor.scopusid | 26040787100 | tr_TR |
dc.subject.scopus | Familial hypercholesterolemia; Lomitapide; Cholesterol | en_US |
dc.subject.emtree | Severity of illness index | en_US |
dc.subject.emtree | Sex difference | en_US |
dc.subject.emtree | Somatization | en_US |
dc.subject.emtree | Symptom checklist 90 | en_US |
dc.subject.emtree | Blood | en_US |
dc.subject.emtree | Exercise | en_US |
dc.subject.emtree | Familial hypercholesterolemia | en_US |
dc.subject.emtree | Homozygote | en_US |
dc.subject.emtree | Mental health | en_US |
dc.subject.emtree | Middle aged | en_US |
dc.subject.emtree | Pathophysiology | en_US |
dc.subject.emtree | Phenotype | en_US |
dc.subject.emtree | Psychology | en_US |
dc.subject.emtree | Questionnaire | en_US |
dc.subject.emtree | Register | en_US |
dc.subject.emtree | Atorvastatin | en_US |
dc.subject.emtree | Ezetimibe | en_US |
dc.subject.emtree | Low density lipoprotein | en_US |
dc.subject.emtree | Rosuvastatin | en_US |
dc.subject.emtree | Hypocholesterolemic agent | en_US |
dc.subject.emtree | Low density lipoprotein cholesterol | en_US |
dc.subject.emtree | Adaptation | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Clinical feature | en_US |
dc.subject.emtree | Cross-sectional study | en_US |
dc.subject.emtree | Demography | en_US |
dc.subject.emtree | Depression | en_US |
dc.subject.emtree | Disease severity | ten_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Global severity index | en_US |
dc.subject.emtree | Healthy lifestyle | en_US |
dc.subject.emtree | Homozygous familial hypercholesterolemia | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Lipoprotein apheresis | en_US |
dc.subject.emtree | Major clinical study | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Mental disease | en_US |
dc.subject.emtree | Obsessive compulsive disorder | en_US |
dc.subject.emtree | Phobia | en_US |
dc.subject.emtree | Physical activity | en_US |
dc.subject.emtree | Prevalence | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Questionnaire | en_US |
dc.subject.emtree | Self report | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.